Pharmaceutical Research

, Volume 28, Issue 2, pp 260–272

Nanoparticles: A Promising Modality in the Treatment of Sarcomas

  • Michiro Susa
  • Lara Milane
  • Mansoor M. Amiji
  • Francis J. Hornicek
  • Zhenfeng Duan
Expert Review

DOI: 10.1007/s11095-010-0173-z

Cite this article as:
Susa, M., Milane, L., Amiji, M.M. et al. Pharm Res (2011) 28: 260. doi:10.1007/s11095-010-0173-z

ABSTRACT

Improvements in surgical technique, chemotherapy, and radiotherapy have enhanced the prognosis of sarcoma patients, but have since reached a plateau in recent years. Novel approaches have been sought but with limited results. Nanomedicine offers solutions in diverse areas of sarcoma therapy including diagnosis and treatment. Several varieties of nanoparticles, including multifunctional nanoparticles, are available that localize the biodistribution of conventional chemotherapeutics to the tumor site. Also, nanoparticles loaded with chemotherapeutic drugs have the ability to overcome drug resistance which is a major obstacle impeding the progress of the treatment. Multifunctional nanoparticles, which have the potential to further augment the bioavailability of drugs, are being actively investigated. In this review, we will discuss the application of nanoparticles for improving the treatment of sarcoma patients.

KEY WORDS

nanoparticle sarcoma tyrosine kinase drug resistance cancer-initiating cell 

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Michiro Susa
    • 1
    • 2
  • Lara Milane
    • 3
  • Mansoor M. Amiji
    • 3
  • Francis J. Hornicek
    • 1
    • 2
  • Zhenfeng Duan
    • 1
    • 2
  1. 1.Department of Orthopaedic SurgeryMassachusetts General HospitalBostonUSA
  2. 2.Sarcoma Biology Laboratory, Center for Sarcoma and Connective Tissue OncologyMassachusetts General HospitalBostonUSA
  3. 3.Department of Pharmaceutical Sciences, School of PharmacyNortheastern UniversityBostonUSA

Personalised recommendations